CHARLES RYAN
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
SCOTT ANCHIN, JOHN BITZER, III, ROBERT B. CATELL, GERALD CATENACCI, JOSEPH D CECCOLI, JOSEPH D. CECCOLI, KAROL GRAY, JAMES HAFT, JAMES A HAYWARD, JAMES A. HAYWARD, BETH JANTZEN, BETH M. JANTZEN, KURT JENSEN, KURT H. JENSEN, JOSHUA KRUGER, MING-HWA LIANG, MING-HWA BENJAMIN LIANG, JUDITH MURRAH, JUDY MURRAH, CHARLES S. RYAN, ELIZABETH M. SCHMALZ FERGUSON, ELIZABETH M. SCHMALZ SHAHEEN, YACOV SHAMASH, YACOV A. SHAMASH, CLAY SHORROCK, CLAY D. SHORROCK, SANFORD R. SIMON
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2026-05-18
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2026-05-18
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-06-18
D
BIOTECHNOLOGY
SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
$1,000,001 - $5,000,000
Debt
2014-09-11
D
BIOTECHNOLOGY
INDUSTRIAL ORGANIC CHEMICALS [2860]
$1,000,001 - $5,000,000
Equity
2014-06-03
D
BIOTECHNOLOGY
INDUSTRIAL ORGANIC CHEMICALS [2860]
$1,000,001 - $5,000,000
Equity
2013-07-19
D
BIOTECHNOLOGY
INDUSTRIAL ORGANIC CHEMICALS [2860]
$1,000,001 - $5,000,000
Equity
2012-11-28
D
BIOTECHNOLOGY
INDUSTRIAL ORGANIC CHEMICALS [2860]
$1 - $1,000,000
Equity
2012-06-21

